Intravitreal injection of VIP-loaded liposomes protected against autoimmune uveitis in rats, demonstrating sustained neuropeptide delivery for treating inflammatory eye disease.
Key findingIntravitreal injection of VIP-loaded liposomes protected against autoimmune uveitis in rats, demonstrating sustained neuropeptide delivery for treatin
What the researchers found
Intravitreal injection of VIP-loaded liposomes protected against autoimmune uveitis in rats, demonstrating sustained neuropeptide delivery for treating inflammatory eye disease.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 25(1), 9-21
Citation
Camelo, Serge; Lajavardi, Laure; Bochot, Amélie; Goldenberg, Brigitte; Naud, Marie-Christine; Brunel, Nadège; Lescure, Bernadette; Klein, Christophe; Fattal, Elias; Behar-Cohen, Francine; de Kozak, Yvonne. (2009). Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 25(1), 9-21. https://doi.org/10.1089/jop.2008.0074